Edwards' Syndrome (Trisomy 18)

oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

Synonyms: trisomy 18, trisomy E syndrome

Edwards' syndrome is trisomy 18, with an extra chromosome 18 instead of the usual pair. It is a severe disorder that can affect all organs in the body.

Mosaics can occur in about 5% of cases in which some cells are normal with 46 chromosomes and others have the extra chromosome. Partial trisomy 18 can (rarely) occur if a segment of chromosome 18 is present in triplicate, usually due to a balanced translocation carried by one parent.

Infants with mosaic and partial trisomy variations tend to be less severely affected.

NEW - log your activity

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »
  • Trisomy 18 is the second most common autosomal trisomy among liveborn children after trisomy 21.
  • Incidence is 1 in 6,000 live births (taking into account prenatal diagnosis and termination of pregnancy).[1]
  • In liveborn infants, it is more likely that the affected infant is female rather than male. This is thought to be due to the fact that male fetuses with trisomy 18 are more likely to be lost due to miscarriage or stillbirth.[2]
  • A personal or close family history of giving birth to an affected child increases the risk.
  • Risk rises with rising maternal age.

Up to 95% of embryos or fetuses with trisomy 18 die.[3]

In the prenatal period there may be:

Features that may be noted after birth include:[1]

  • Edwards' syndrome and Patau's syndrome can have similar features and be difficult to differentiate.
  • Pena-Shokeir syndrome is also known as pseudo-trisomy 18.[1]
  • Cytogenetic studies and chromosomal analysis will confirm the diagnosis.
  • Organ systems will need specific investigation depending on the abnormality, eg echocardiography for cardiac abnormalities, skeletal radiography, etc.
  • Treatment of a liveborn infant is generally supportive but life-sustaining measures are not always carried out. Considerable thought and discussion are recommended before undertaking measures such as surgical correction of abnormalities. Nasogastric or gastrostomy feeding is feasible but the clinician should take into account the wishes of the parents and any potential harms it may cause the infant.
  • Median life expectancy is 4 days. However, about 5-10% survive beyond one year, so the mean age at death is 48 days.[1]
  • Useful statistics include:
    • Newborns have a 40% chance of surviving to age 1 month.
    • Infants have a 5% chance of surviving to age 1 year.
    • Children have a 1% chance of surviving to age 10 years.[3]
  • Those who survive have an increased risk of Wilms' tumour and hepatoblastoma.[1]
  • Death is usually due to severe cardiac, renal or central nervous system malformation, feeding difficulties or sepsis.[3]

Parents will need a great deal of support and counselling. Support organisations may be useful:

  • If Edwards' syndrome is due to an unbalanced translocation, both parents should undergo chromosomal analysis. It may be that the translocation in the infant occurred de novo but a balanced translocation may be found in one of the parents. This has significance for future pregnancies. Other family members may also be affected.[1]
  • Screening and/or prenatal diagnosis should be offered for future pregnancies.
  • For full trisomy 18, the risk of recurrence in a future pregnancy is less than 1%.[3] Risk may be higher if a parent carries a balanced translocation. Referral should be made to a geneticist as appropriate.
  • Serum screening that is currently carried out for Down's syndrome may help to identify not only fetuses at risk of Down's syndrome but also those at risk of trisomy 13 and 18.
  • A recent study looked at screening for trisomy 18 by using maternal age, fetal nuchal translucency, free beta human chorionic gonadotrophin (beta-hCG) and pregnancy-associated plasma protein-A, alongside screening for trisomy 21. More than 95% of trisomy 18 fetuses were detected.[4]
  • Another study concluded that the addition of a trisomy 18-specific risk algorithm in the second trimester achieved high detection rates for aneuploidies other than Down's syndrome. In this study, all patients had a nuchal scan in the first trimester, and those without cystic hygroma had a combined test (nuchal translucency, pregnancy-associated plasma protein-A (PAPP-A), free beta-hCG) and returned at 15-18 weeks for a quadruple screen using serum alpha-fetoprotein, total hCG, unconjugated estriol (uE3) and inhibin-A.[5]
  • Ultrasound: typical structural abnormalities may be detected on prenatal ultrasound and may raise the suspicion of Edwards' syndrome. Examples include persistent abnormal hand/finger position, choroid plexus cysts, cardiac defects, two-vessel umbilical cord.[3][6][7] A second-trimester anatomical screening by ultrasound appears to be a good method of detection.[8]

Trisomy 18 was described by Edwards et al in April 1960[9] and by Smith et al in September 1960.[10] It was John Edwards who gained the eponym.

Further reading & references

  1. Leask K; Edwards Syndrome, National Library for Health, Genetic Conditions Specialist Library, July 2005
  2. Morris JK, Savva GM; The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet A. 2008 Apr 1;146(7):827-32.
  3. Chen H; Trisomy 18, eMedicine, Jul 2009
  4. Kagan KO, Wright D, Maiz N, et al; Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008 Sep;32(4):488-92.
  5. Breathnach FM, Malone FD, Lambert-Messerlian G, et al; First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol. 2007 Sep;110(3):651-7.
  6. Papp C, Ban Z, Szigeti Z, et al; Role of second trimester sonography in detecting trisomy 18: a review of 70 cases. J Clin Ultrasound. 2007 Feb;35(2):68-72.
  7. Moyano D, Huggon IC, Allan LD; Fetal echocardiography in trisomy 18. Arch Dis Child Fetal Neonatal Ed. 2005 Nov;90(6):F520-2. Epub 2005 May 24.
  8. Bronsteen R, Lee W, Vettraino IM, et al; Second-trimester sonography and trisomy 18.; J Ultrasound Med. 2004 Feb;23(2):233-40.
  9. Edwards JH, Harnden DG, Cameron AH, et al; A new trisomic syndrome.; Lancet. 1960 Apr 9;1:787-90.
  10. Smith DW, Patau K, Therman E, et al; A new autosomal trisomy syndrome: multiple congenital anomalies caused by an extra chromosome.; J Pediatr. 1960 Sep;57:338-45.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Michelle Wright
Current Version:
Last Checked:
18/03/2011
Document ID:
2089 (v22)
© EMIS